Janux Therapeutics logo

Janux Therapeutics share price today

(JANX)

Janux Therapeutics share price is $61.5 & ₹5,217.05 as on 13 Dec 2024, 2.30 'hrs' IST

$61.5

-1.95

(-3.07%)

Market is closed - opens 8 PM, 13 Dec 2024

View live Janux Therapeutics share price in Dollar and Rupees. Guide to invest in Janux Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Janux Therapeutics. Get details on the Indian mutual funds that are investing in Janux Therapeutics. Get Analyst recommendations and forecasts along with all the Janux Therapeutics's financials.

Janux Therapeutics share price movements

  • $61.27
    $64.90

    Day's Volatility :5.59%

  • $7.79
    $71.71

    52 Weeks Volatility :89.14%

Janux Therapeutics Returns

PeriodJanux Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
22.98%
-9.7%
0.0%
6 Months
46.43%
-3.4%
0.0%
1 Year
472.09%
3.7%
0.0%
3 Years
236.62%
3.8%
-18.9%

Janux Therapeutics Key Statistics

in dollars & INR

Previous Close
$63.45
Open
$64.0
Today's High
$64.9
Today's Low
$61.27
Market Capitalization
$3.7B
Today's Volume
$891.6K
52 Week High
$71.71
52 Week Low
$7.79
Revenue TTM
$13.0M
EBITDA
$-83.9M
Earnings Per Share (EPS)
$-1.17
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-12.05%

How to invest in Janux Therapeutics from India?

It is very easy for Indian residents to invest directly in Janux Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Janux Therapeutics stock in both rupees (INR) and dollars (USD). Search for Janux Therapeutics or JANX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Janux Therapeutics or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Janux Therapeutics shares which would translate to 0.014 fractional shares of Janux Therapeutics as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Janux Therapeutics

221.21%

Period: Sep 13, 2024 to Dec 12, 2024. Change in 30 Days versus previous period

Investment in Janux Therapeutics from India has grown in the last 30 days as on Dec 13, 2024. 221.21% more purchase transactions for Janux Therapeutics in the last 30 days versus the previous period.

91%

Period: Sep 13, 2024 to Dec 12, 2024. Change in 30 Days versus previous period

Search volume for Janux Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 13, 2024. 91% more investors are searching Janux Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Janux Therapeutics

  • RA Capital Management, LLC

    17.46%

  • FMR Inc

    14.91%

  • HHG PLC

    4.81%

  • Paradigm Biocapital Advisors LP

    4.57%

  • BlackRock Inc

    4.47%

  • Adage Capital Partners Gp LLC

    3.95%

Analyst Recommendation on Janux Therapeutics

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Janux Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Janux Therapeutics

What analysts predicted

Upside of 49.0%

Current:

$61.50

Target:

$91.64

Insights on Janux Therapeutics

  • Price Movement

    In the last 1 year, JANX stock has moved up by 507.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 8.89M → 439.0K (in $), with an average decrease of 95.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -5.95M → -28.05M (in $), with an average decrease of 370.9% per quarter

Janux Therapeutics Technicals Summary

Sell

Neutral

Buy

Janux Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Janux Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Janux Therapeutics Inc
18.29%
46.43%
472.09%
236.62%
121.3%
Regeneron Pharmaceuticals, Inc.
-7.88%
-28.51%
-15.41%
10.43%
97.06%
Biontech Se
8.26%
31.07%
16.1%
-56.39%
244.83%
Alnylam Pharmaceuticals, Inc.
-7.31%
52.91%
31.52%
32.05%
104.18%
Vertex Pharmaceuticals Incorporated
-6.16%
-3.46%
14.15%
121.81%
111.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Janux Therapeutics Inc
NA
NA
NA
-1.26
-0.12
-0.1
NA
12.54
Regeneron Pharmaceuticals, Inc.
19.12
19.12
1.15
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.12
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Janux Therapeutics Inc
Buy
$3.7B
121.3%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$84.9B
97.06%
19.12
33.61%
Biontech Se
Buy
$28.6B
244.83%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.8B
104.18%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
111.44%
32.84
-4.51%

Janux Therapeutics Dividend announcements

  • Janux Therapeutics Earnings

    Janux Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Janux Therapeutics

janux therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary tumor activated t cell engager (tractr) platform technology to better treat patients suffering from cancer. janux’s initial focus is on developing a novel class of t cell engagers (tces), and its lead product candidates are designed to target clinically validated drug targets. while tce therapeutics have displayed potent anti-tumor activity in hematological cancers, developing tces to treat solid tumors have faced challenges due to the limitations of prior tce technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. janux is using its tractr platform technology to engineer product candidates designed to overcome these limitations. janux is developing a broad pipeline with lead programs targeting prostate-specific membr
Organization
Janux Therapeutics
Employees
76
CEO
Dr. David Alan Campbell Ph.D.
Industry
Services

Management People of Janux Therapeutics

NameTitle
Dr. David Alan Campbell Ph.D.
President, CEO & Director
Mr. Charles M. Winter
Chief Technical Officer
Mr. Byron Robinson J.D., Ph.D.
Chief Strategy Officer
Mr. Matt Whitmire
Vice President of Finance
Ms. Maria Dobek
Principal Accounting Officer & VP of Accounting
Dr. Tommy Diraimondo Ph.D.
Chief Scientific Officer
Mr. James Pennington
General Counsel
Mr. Andy Hollman Meyer
Chief Business Officer

Important FAQs about investing in Janux Therapeutics from India :

What is Janux Therapeutics share price today?

Janux Therapeutics (JANX) share price today is $61.50.

Can Indians buy Janux Therapeutics shares?

Yes, Indians can invest in the Janux Therapeutics (JANX) from India.

With INDmoney, you can buy Janux Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Janux Therapeutics at zero transaction cost.

How can I buy Janux Therapeutics shares from India?

It is very easy to buy Janux Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Janux Therapeutics be purchased?

Yes, you can buy fractional shares of Janux Therapeutics with INDmoney app.

What are the documents required to start investing in Janux Therapeutics stocks?

To start investing in Janux Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Janux Therapeutics

Today’s highest price of Janux Therapeutics (JANX) is $64.90.

Today’s lowest price of Janux Therapeutics (JANX) is $61.27.

What is today's market capitalisation of Janux Therapeutics

Today's market capitalisation of Janux Therapeutics JANX is 3.7B

What is the 52 Week High and Low Range of Janux Therapeutics

  • 52 Week High

    $71.71

  • 52 Week Low

    $7.79

How much percentage Janux Therapeutics is down from its 52 Week High?

Janux Therapeutics (JANX) share price is $61.50. It is down by 14.24% from its 52 Week High price of $71.71.

How much percentage Janux Therapeutics is up from its 52 Week low?

Janux Therapeutics (JANX) share price is $61.50. It is up by 689.47% from its 52 Week Low price of $7.79.

What are the historical returns of Janux Therapeutics?

  • 1 Month Returns

    18.29%

  • 3 Months Returns

    46.43%

  • 1 Year Returns

    472.09%

  • 5 Years Returns

    121.3%

Who is the Chief Executive Officer (CEO) of Janux Therapeutics

Dr. David Alan Campbell Ph.D. is the current Chief Executive Officer (CEO) of Janux Therapeutics.